Quick Facts at a Glance
- Recall Date
- February 13, 2026
- Hazard Level
- HIGH
- Brand
- Medtronic MiniMed
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- Medtronic MiniMed
- Product type
- Insulin Pump
- Model numbers
- MMT-554, MMT-754, Paradigm REAL-Time Veo, Paradigm Veo
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
February 13, 2026
Reported by FDA DEVICE
April 8, 2026
RecallRadar source check
April 15, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter
About This Product
Insulin pumps deliver continuous insulin to help manage diabetes. The Paradigm Veo system is part of Medtronic’s older Paradigm line and 600/700 series.
Why This Is Dangerous
The device’s insulin delivery can be incorrect due to pump height changes, affecting pressure at the infusion site. Over-delivery risks hypoglycemia and death; under-delivery risks hyperglycemia and death.
Industry Context
This recall is not described as part of a broader safety pattern in the provided data.
Real-World Impact
Patients could experience dangerous blood glucose fluctuations. Immediate action is required to prevent harm and stabilize treatment.
Practical Guidance
How to identify if yours is affected
- 1. Locate model number on device label (MMT-554 or MMT-754).
- 2. Confirm Paradigm REAL-Time Veo branding.
- 3. Check the FDA recall page for Z-1752-2026 and Medtronic communications.
Where to find product info
FDA enforcement page and Medtronic recall notices on medtronic.com
What timeline to expect
Refunds or replacements typically follow manufacturer guidance within weeks to months.
If the manufacturer is unresponsive
- Escalate to the consumer protection agency in your country (eg, CPSC in the U.S.).
- Seek assistance from your healthcare provider.
- Document all contact attempts and keep copies of correspondence.
How to prevent similar issues
- Stay aware of recall notices for any medical device.
- Ask healthcare providers about safer pump options if you require continued insulin delivery.
- Keep a current list of emergency contacts and glucose monitoring supplies.
Documentation advice
Keep device label, model numbers, recall notices, and all correspondence with manufacturer. Document symptoms and medical visits related to recall events.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
Model numbers: MMT-554 and MMT-754. Product: Paradigm REAL-Time Veo Insulin Pump. Sold worldwide. Recall date: 2026-02-13. Quantity: 55,724. Manufacturer: Medtronic MiniMed, Inc. Price: Not disclosed. Country of origin: Unknown.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
- 55,724 units recalled worldwide
- Paradigm REAL-Time Veo insulin pumps included (MMT-554, MMT-754)
- Over-delivery when pump is raised; under-delivery when lowered
- No injuries or incidents reported (per recall)
- Stop using the device and await instructions from Medtronic MiniMed
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.